Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-THK5351 PET in Parkinsonian Tauopathies
NCT03386669Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jul 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 18F-THK5351 in progressive supranuclear palsy (PSP), Corticobasal Syndrome (CBS), Parkinson's disease (PD), sponsored by Chang Gung Memorial Hospital. Started Jul 2017; status: completed.
02
Drugs
18F-THK5351
03
Conditions
progressive supranuclear palsy (PSP)Corticobasal Syndrome (CBS)Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03386669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03386669.